Cargando…
Decreased serum level of sphingosine‐1‐phosphate: a novel predictor of clinical severity in COVID‐19
The severity of coronavirus disease 2019 (COVID‐19) is a crucial problem in patient treatment and outcome. The aim of this study is to evaluate circulating level of sphingosine‐1‐phosphate (S1P) along with severity markers, in COVID‐19 patients. One hundred eleven COVID‐19 patients and forty‐seven h...
Autores principales: | Marfia, Giovanni, Navone, Stefania, Guarnaccia, Laura, Campanella, Rolando, Mondoni, Michele, Locatelli, Marco, Barassi, Alessandra, Fontana, Laura, Palumbo, Fabrizio, Garzia, Emanuele, Ciniglio Appiani, Giuseppe, Chiumello, Davide, Miozzo, Monica, Centanni, Stefano, Riboni, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744841/ https://www.ncbi.nlm.nih.gov/pubmed/33190411 http://dx.doi.org/10.15252/emmm.202013424 |
Ejemplares similares
-
Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks
por: Riboni, Laura, et al.
Publicado: (2020) -
Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro‐oncology
por: Marfia, Giovanni, et al.
Publicado: (2022) -
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
por: Guarnaccia, Laura, et al.
Publicado: (2021) -
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics
por: Guarnaccia, Laura, et al.
Publicado: (2022) -
Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy
por: Guarnaccia, Laura, et al.
Publicado: (2018)